Factor VIII genotype and the risk of developing high-responding or low-responding inhibitors in severe hemophilia A: data from the PedNet Hemophilia Cohort of 1,202 children
Nadine G. Andersson,
Veerle Labarque,
Mutlu Kartal-Kaess,
Fernando Pinto,
Torben Stamm Mikkelsen,
Rolf Ljung,
PedNet Study Group
Affiliations
Nadine G. Andersson
Center for Thrombosis and Hemostasis, Skåne University Hospital, Malmö, Sweden; Department of Pediatrics, Skåne University Hospital, Lund, Sweden; Department of Clinical Sciences and Pediatrics, Lund University, Lund
Veerle Labarque
Department of Pediatrics, Pediatric Hematology and Oncology, University Hospitals Leuven, Leuven, Belgium
Mutlu Kartal-Kaess
Division of Pediatric Hematology and Oncology, Department of Pediatrics, Inselspital, University Hospital, University of Bern, Bern
Fernando Pinto
Royal Hospital for Children, Glasgow, UK
Torben Stamm Mikkelsen
Department of Pediatric Oncology and Hematology, University Hospital, Aarhus, Denmark
Rolf Ljung
Department of Pediatrics, Skåne University Hospital, Lund
